Jpmorgan Chase & Co »

Indaptus Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Indaptus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $24 19 1.26
2024-06-30 $31 15 2.13
2024-03-31 $31 14 2.21
2023-12-31 $16 9 1.78
2023-09-30 $19 7 2.71